Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03009110 · ClinicalTrials.gov registry record · NA
Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 1,624
- Enrollment target
NCT03009110: Clinical Trial NA study, sponsored by Indiana University.
NCT03009110 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 1,624 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03009110, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,624 participants
- Enrollment target
Study Summary
The Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean Trial is a large pragmatic multi-center randomized clinical trial designed to evaluate the effectiveness, safety and cost-effectiveness of prophylactic negative pressure wound therapy (NPWT) - a closed, sealed system that applies negative pressure to the wound surface via a single-use, battery-powered, portable device - to decrease surgical site infections (SSIs) in obese women.
Primary Outcome
As defined according to the Center for Disease Control and Prevention's (CDC) National Healthcare Safety Network criteria.
Interventions
- DEVICE Standard Dressing
- DEVICE Prophylactic NPWT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,624 participants |
| Start Date | 2017-02-08 |
| Est. Completion | 2019-11-13 |
| Phase | NA |
Why NCT03009110 stopped before completion
NCT03009110 is an interventional study that assigns participants to a tested intervention. Its 1,624 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% higher).
The record links to 0 conditions, and to 2 interventions - of which Standard Dressing is the first listed.
NCT03009110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03009110 about?
NCT03009110 is a clinical study titled "Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial". The Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean Trial is a large pragmatic multi-center randomized clinical trial designed to evaluate the effectiveness, safety and cost-effectiveness of prophylactic negative pressure wound therapy (NPWT) - a closed, sealed system that ap...
What is the current status of trial NCT03009110?
This trial is currently terminated. It is a NA study. The enrollment target is 1,624 participants. The study started on 2017-02-08. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT03009110?
The interventions under investigation include: Standard Dressing (DEVICE), Prophylactic NPWT (DEVICE).
Who is sponsoring clinical trial NCT03009110?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03009110's enrollment target sits among peer trials
1,624 63rd of 2000 higher than 1,938 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI